Millennium Pharmaceuticals currently markets a leading oncology product,
VELCADE® (bortezomib) for Injection. Millennium expects to develop drugs in two key therapeutic areas:
The company also has a significant number of investigational drugs at various stages of clinical and preclinical development, as described in the
R&D section of this website.
